CMBA
BSX icon

C.M. Bidwell & Associates’s Boston Scientific BSX Stock Holding History

C.M. Bidwell & Associates’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,495
Closed -$429K – 484
2025
Q4 		$429K Sell
4,495
-35
-0.8% -$3.43K 0.2% 70
2025
Q3 		$442K Sell
4,530
-196
-4% -$20.3K 0.21% 72
2025
Q2 		$508K Sell
4,726
-125
-3% -$12.6K 0.26% 66
2025
Q1 		$489K Buy
4,851
+2,880
+146% +$290K 0.29% 62
2024
Q4 		$176K Hold
1,971
– – 0.11% 137
2024
Q3 		$165K Buy
+1,971
New +$155K 0.1% 142
2020
Q1 		– Sell
-124
Closed -$6K – 366
2019
Q4 		$6K Hold
124
– – 0.01% 323
2019
Q3 		$5K Buy
+124
New +$5.25K ﹤0.01% 337
2016
Q4 		– Sell
-157,805
Closed -$3.76M – 238
2016
Q3 		$3.76M Buy
+157,805
New +$3.76M 0.9% 55
2015
Q2 		– Sell
-191,160
Closed -$3.39M – 220
2015
Q1 		$3.39M Sell
191,160
-304,105
-61% -$4.81M 0.75% 66
2014
Q4 		$6.56M Sell
495,265
-655
-0.1% -$8.37K 1.5% 21
2014
Q3 		$5.86M Sell
495,920
-35,540
-7% -$448K 1.38% 16
2014
Q2 		$6.79M Sell
531,460
-60
-0% -$780 1.55% 12
2014
Q1 		$7.19M Buy
531,520
+3,935
+0.7% +$51.6K 1.73% 10
2013
Q4 		$6.34M Sell
527,585
-1,320
-0.2% -$15.6K 1.57% 15
2013
Q3 		$6.21M Sell
528,905
-4,625
-0.9% -$50K 1.71% 12
2013
Q2 		$4.95M Buy
+533,530
New +$4.53M 1.45% 19

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

C.M. Bidwell & Associates's BSX Position: Q1 2026 in Review

C.M. Bidwell & Associates sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 4,495 shares — an estimated $429K sold.

C.M. Bidwell & Associates first reported a position in BSX in Q2 2013 and held it in 17 quarters. The position peaked at $7.19M in Q1 2014. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • C.M. Bidwell & Associates reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 4,495 Boston Scientific shares in Q1 2026, an estimated $429K.
  • C.M. Bidwell & Associates first reported a position in Boston Scientific in Q2 2013 and held it in 17 quarters.
  • C.M. Bidwell & Associates's Boston Scientific position peaked at $7.19M in Q1 2014.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.